Chicago, Illinois
January 31, 2007
Chromatin, Inc., a
leader in the design, delivery and use of mini-chromosomes,
announced that the United States Patent and Trademark Office has
issued U.S. Patent No. 7,119,250 entitled Plant centromere
compositions. This landmark patent permits construction of
mini-chromosomes as vectors for plant and animal cells and
includes techniques for creating transgenic plants using
engineered mini-chromosomes. Importantly, this patent is not
specific to a particular plant species, but instead provides
Chromatin with exclusive rights to use mini-chromosome
technology in all plants.
The issued patent covers technology developed by Drs. Daphne
Preuss, Gregory Copenhaver and Kevin Keith at The University of
Chicago. The patent has been exclusively licensed to Chromatin
and allows the Company to sublicense the technology for
commercial development. It further strengthens Chromatin’s
intellectual property position, adding to the Company’s
portfolio of over 40 patents, applications and inventions that
cover the design, delivery and use of mini-chromosomes.
Alan Thomas, director of U Chicago Tech, the technology-transfer
office at the University of Chicago, said “This is an important
patent for the University and Chromatin, and reflective of the
breadth and impact of this technology." Progress at Chromatin is
also featured as an example of an unusually promising and
successful tech-transfer project in the February 1, 2007 issue
of the University of Chicago Chronicle.
In addition to awarding Chromatin exclusive rights to
mini-chromosomes in plants, this patent also describes
technology that makes it possible to add several genes (“gene
stacks”) simultaneously to a plant, reducing the time and
expense to commercialize new products. In addition, the
identification of nucleic acid sequences that function as plant
centromeres has allowed Chromatin to generate stably inherited
DNA constructs and mini-chromosomes in several plant species.
Chromatin, Inc. develops and markets novel proprietary
technology that enables entire chromosomes to be designed and
incorporated into plant cells. These engineered chromosomes make
it possible for the first time to simultaneously introduce
multiple genes into a plant cell while maintaining precise
control of gene expression. Chromatin is employing these new
genetic tools to design and market products that confer
commercially valuable traits in plants, including improved
nutritional and health characteristics, and can be used for
industrial, agricultural and pharmaceutical product development. |